相关实验视频
Updated: Jun 9, 2025

10:37
Ferric Chloride-induced Murine Thrombosis Models
Published on: September 5, 2016
21.5K
具有降低PAR4反应性的小鼠显示静脉血栓塞和血小板前凝剂活性降低
Elizabeth A Knauss1, Johana Guci1, Norman Luc2
1Case Western Reserve University, School of Medicine, Department of Pharmacology, Cleveland, OH United States.
bioRxiv : the preprint server for biology
|October 28, 2024
概括
在PAR4 (rs2227376) 中的一个遗传变异减少了血栓生成,降低了静脉血栓栓塞 (VTE) 的风险. 这项研究证实了小鼠中PAR4-322L突变的保护机制,突出了PAR4信号传导.
科学领域:
- 生物化学 生化学
- 遗传学 是一个遗传学.
- 血液学 血液学 血液学
背景情况:
- 高凝血和过度的血栓生成是静脉血栓形成的关键危险因素.
- 通过蛋白酶激活受体4 (PAR4) 持续发送的血素信号促进了血小板激活和血素生成.
- 在PAR4中,单核酸多态性 (rs2227376) 导致氨酸替代氨酸 (P310L),降低了PAR4的反应性,并与较低的静脉血栓栓塞栓症 (VTE) 风险有关.
研究的目的:
- 阐明rs2227376多态和减少VTE风险之间的机制联系.
- 在小鼠模型中研究同类PAR4-P322L突变的体内功能.
主要方法:
- 使用PAR4-P322L突变小鼠在下静脉静脉静止和狭窄模型中评估静脉血栓形成.
- 使用旋转性血栓形成显微镜 (ROTEM) 测量了凝血和凝块稳定性.
- 通过流动细胞计量评估了富含血小板血中的血栓生成潜力,并分析了脂胺暴露和血小板-中性粒细胞聚合.
主要成果:
- 具有PAR4-P322L突变 (PAR4P/L和PAR4L/L) 的小鼠在48小时后表现出静脉血栓发生率和大小的减少.
- PAR4P/L和 PAR4L/L血小板在刺激时显示酸丁素暴露减少,导致血栓生成减少.
- 在PAR4-P322L小鼠中,PAR4介导的血小板-中性粒细胞聚合减少.
结论:
- 素等位基因 (PAR4-322L) 会导致更少的血小板凝固剂和减少内源性血栓潜力.
- 这种受损的血栓生成能力为PAR4-322L对VTE的保护作用提供了一种机制.
- 这些发现强调了PAR4信号在静脉血栓塞栓症的发病过程中的关键作用.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
625
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
625
Venous Thrombosis III: Interprofessional Care
2
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
2
Venous Thrombosis I: Introduction
2
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
2
Clot Retraction and Fibrinolysis
4.4K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
4.4K
Formation of the Platelet Plug
4.8K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
4.8K
Disorders of Hemostasis
726
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
726

